<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03465124</url>
  </required_header>
  <id_info>
    <org_study_id>1053/2018</org_study_id>
    <nct_id>NCT03465124</nct_id>
  </id_info>
  <brief_title>Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery</brief_title>
  <acronym>FLAME</acronym>
  <official_title>Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery - FLAME</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigational device is an approved femtosecond laser (FSL) device with an integrated
      imaging system to perform certain steps of the cataract procedure. The FSL will perform
      anterior capsulotomy and lens fragmentation in individuals suffering from age-related
      cataract with need of cataract surgery.

      Cataract surgery will be performed in subjects who have signed an informed consent form.
      Macula thickness will be measured with Spectralis OCT on screening date.

      Postoperative examinations will be implemented in accordance with the approved
      investigational plan on subjects and includes: visual acuity, slitlamp examination, retinal
      oct imaging and quantitative autofluorescence.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">November 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Bilateral cataract surgery will be performed in individuals with age-related cataract. Eyes will be randomized into two groups receiving either Femtosecond Laser assisted Cataract Surgery (LCS) or conventional Manual Cataract Surgery (MCS).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before procedure start.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Central Macular Thickness</measure>
    <time_frame>Baseline to 6 weeks postoperative</time_frame>
    <description>Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Influence of lens density on quantitative autofluorescence</measure>
    <time_frame>Baseline to 1 weel, 3 weeks and 6 weeks postoperative</time_frame>
    <description>Influence of lens density on quantitative autofluorescence will be assessed in qAF units. Images will be recorded after volume scans for each eye on designated visits.
Quantitative Autofluorescence quantifies natural fundus autofluorescence with a Spectralis HRA+OCT. This method uses the same wavelength and confocal scanning laser ophthalmoscope as fundus autofluorescence (488nm; maximum power: 280 ÂµW) and can be used to determine the integrity and vitality of the retinal pigment epithelium which is important for nourishment the retina.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Macular Thickness</measure>
    <time_frame>Baseline to 1 week, 3 weeks, 6 weeks postoperative</time_frame>
    <description>Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Age Related Cataracts</condition>
  <condition>Cystoid Macular Edema</condition>
  <arm_group>
    <arm_group_label>Femtosecond Laser assisted Cataract Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual Cataract Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manual Cataract Surgery will be performed in contralateral (to LCS) eye of patient with bilateral age-related cataract.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond Laser</intervention_name>
    <description>Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order. Contralateral eye will receive conventional cataract surgery</description>
    <arm_group_label>Femtosecond Laser assisted Cataract Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual Cataract Surgery</intervention_name>
    <description>conventional cataract surgery as control</description>
    <arm_group_label>Manual Cataract Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral Age-related cataract necessitating lens extraction and posterior IOL
             implantation

          -  Age 40 and older (females of childbearing age will be interviewed if pregnancy is
             possible)

        Exclusion Criteria:

          -  Corneal abnormality

          -  Preceding ocular surgery or trauma

          -  Uncontrolled glaucoma

          -  Proliferative diabetic retinopathy

          -  Macular degeneration

          -  Iris neovascularization

          -  History of uveitis/iritis

          -  Microphthalmus

          -  Recurrent intraocular inflammation of unknown etiology

          -  Blind fellow eye

          -  Uncontrolled systemic or ocular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rupert Menapace, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Universitiy of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luca Schwarzenbacher, MD</last_name>
    <phone>+43140400</phone>
    <phone_ext>79450</phone_ext>
    <email>luca.schwarzenbacher@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christina Leydolt, MD</last_name>
    <phone>+43140400</phone>
    <phone_ext>79480</phone_ext>
    <email>christina.leydolt@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupert Menapace, MD</last_name>
      <phone>+43140400</phone>
      <phone_ext>66300</phone_ext>
      <email>rupert.menapace@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Christina Leydolt, MD</last_name>
      <phone>+43140400</phone>
      <phone_ext>79480</phone_ext>
      <email>christina.leydolt@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rupert Menapace</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

